← Open Payments lookup

KYLEE MALIWAUKI: Open Payments

NPI 1417622614 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,201 in 132 payments from 34 companies in 2025. Trend: 2023 $1,513 · 2024 $2,796 · 2025 $3,201

Food & beverage: $2,737Long term medical supply or device loan: $299Education: $165
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation20$608
AstraZeneca Pharmaceuticals LP14$342
Daiichi Sankyo Inc.14$309
Merck Sharp & Dohme LLC8$195
SEAGEN INC.2$165
Janssen Biotech, Inc.7$160
ARRAY BIOPHARMA INC9$116
Takeda Pharmaceuticals U.S.A., Inc.4$114
ABBVIE INC.5$106
GlaxoSmithKline, LLC.5$83

Products named: Enhertu, KISQALI, KEYTRUDA, IMFINZI, SCEMBLIX, Fabhalta, TECVAYLI, CALQUENCE.

Industry payments across UT — which companies pay providers there.